Electromagnetic fields do not pose a health hazard to energy workers

NewsGuard 100/100 Score

Electromagnetic fields do not pose a health hazard to workers in the electrical energy supply industry, suggests a large study of 28,000 people, published ahead of print in Occupational and Environmental Medicine.

Exposure to low frequency electromagnetic fields of 50 to 60 Hz has been implicated in an increased risk of leukaemia, brain and breast cancers.

The researchers used the health and employment records of more than 22,000 utility workers at 99 different electrical energy supply companies in Denmark.

All the employees had been employed at the companies for a minimum of three months since 1968, and they were tracked for an average of nearly 23 years or until death..

When the data were linked to the Danish Cancer Registry where all new cases of cancer in the country have been recorded since 1942, the researchers found ,no compelling evidence, for an increased risk of leukaemia, breast or brain cancers.

There were no excess cases of leukaemia among men or of breast cancer among female employees who had been exposed to medium to high frequency magnetic fields.

Women exposed to medium frequency electromagnetic fields were more likely to develop brain cancer than women with background frequency levels.

But this was not true of men who had been exposed to high frequency magnetic fields. They were less likely to develop the disease.

The researchers conclude that their findings agree with those of the International Agency for Research on Cancer in 2002

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis